6
Y. Yang et al. / Tetrahedron xxx (2018) 1e7
174.3. HRMS-ESI (m/z): calcd for C26H29N2O5S2 (MþHþ): 513.1512,
(m/z): calcd for C27H31N2O5S2 (MþHþ): 527.1669, found 527.1667.
found 513.1519.
4.4.14. N-(3-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)acetamide (2n)
4.4.8. N-(4-((N-(Phenylsulfonyl)phenylsulfonamido)methyl)-
phenyl)benzamide (2h)11a
Yellow solid, mp 128e130 ꢁC; IR (KBr, cmꢀ1): 1164, 1371, 1667,
White solid, mp 130e132 ꢁC; IR (KBr, cmꢀ1): 1171, 1371, 1668,
3068, 3256. 1H NMR (400 MHz, CDCl3):
d
2.15 (s, 3H), 2.27 (s, 3H),
4.97 (s, 2H), 6.95e6.97 (m, 1H), 7.13e7.15 (m, 1H), 7.33e7.35 (m,
2H), 7.42e7.46 (m, 4H), 7.56e7.60 (m, 2H), 7.79e7.81 (m, 4H), 13
NMR (100 MHz, CDCl3): 19.3, 24.6, 49.8, 117.2, 121.4, 128.0, 128.1,
2923, 3399. 1H NMR (400 MHz, CDCl3):
d 4.92 (s, 2H), 7.37 (s, 1H),
7.40 (s, 1H), 7.44e7.48 (m, 4H), 7.51e7.55 (m, 4H), 7.56e7.60 (m,
C
4H), 7.81 (d, J ¼ 8.12 Hz, 4H), 7.89e7.91 (m, 2H), 13C NMR (100 MHz,
d
CDCl3):
d 52.0, 120.0, 127.0, 128.1, 128.8, 128.9, 130.1, 130.6, 132.0,
128.5, 128.8, 130.0, 133.7, 137.5, 139.9, 168.3. HRMS-ESI (m/z): calcd
for C22H23N2O5S2 (MþHþ): 459.1043, found 459.1042.
133.7, 134.8, 137.9, 140.0, 165.6. HRMS-ESI (m/z): calcd for
C
26H22N2O5S2 (MþHþ): 506.5933, found 506.5931.
4.4.15. N-(3-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)propionamide (2o)
4.4.9. N-(2-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)acetamide (2i)
Yellow solid, mp 140e142 ꢁC; IR (KBr, cmꢀ1): 1162, 1370, 1657,
Yellow solid, mp 120e122 ꢁC; IR (KBr, cmꢀ1): 1171, 1375, 1652,
2923, 3413. 1H NMR (400 MHz, CDCl3):
d 1.22e1.24 (m, 3H), 2.27 (s,
3H), 2.35e2.41 (m, 2H), 4.97 (s, 2H), 6.97e6.99 (m, 1H), 7.13e7.15
(m, 1H), 7.22 (s, 1H), 7.30e7.32 (m, 1H), 7.42e7.46 (m, 4H),
7.56e7.60 (m, 2H) 7.80e7.82 (m, 4H), 13C NMR (100 MHz, CDCl3):
2920, 3404. 1H NMR (400 MHz, CDCl3):
d 2.10 (s, 3H), 2.22 (s, 3H),
4.88 (s, 2H), 7.01 (s, 1H), 7.10 (s,1H), 7.17e7.19 (m, 1H), 7.43e7.47 (m,
4H), 7.56 (t, J ¼ 7.52 Hz, 2H), 7.63e7.65 (m, 1H), 7.79 (d, J ¼ 7.60 Hz,
4H), 13C NMR (100 MHz, CDCl3):
d 17.6, 24.3, 52.1, 123.4, 127.6, 128.1,
d
9.6, 19.3, 30.7, 49.8, 117.1, 121.4, 127.9, 128.1, 128.5, 128.9, 130.0,
128.4, 128.9, 130.1, 133.5, 133.7, 135.5, 140.0, 168.5. HRMS-ESI (m/z):
calcd for C22H23N2O5S2 (MþHþ): 459.1043, found 459.1039.
133.7, 137.4, 139.9, 172.0. HRMS-ESI (m/z): calcd for C23H25N2O5S2
(MþHþ): 473.1199, found 473.1200.
4.4.10. N-(2-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)propionamide (2j)
4.4.16. N-(3-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)butyramide (2p)
Yellow solid, mp 75e77 ꢁC; IR (KBr, cmꢀ1): 1169, 1370, 1658,
2923, 3394. 1H NMR (400 MHz, CDCl3):
d
1.29e1.31 (m, 3H), 2.11 (s,
Yellow solid, mp 88e89 ꢁC; IR (KBr, cmꢀ1): 1168, 1371, 1687,
3H), 2.42 (dd, J1 ¼6.80 Hz, J2 ¼ 14.0 Hz, 2H), 4.88 (s, 2H), 6.93 (s, 1H),
7.11 (s, 1H), 7.18e7.20 (m, 1H), 7.43 (s, 1H), 7.45e7.47 (m, 4H),
7.57e7.60 (m, 2H), 7.79e7.81 (m, 4H), 13C NMR (100 MHz, CDCl3):
2927, 3379. 1H NMR (400 MHz, CDCl3):
d 0.99e1.00 (m, 3H),
1.73e1.79 (m, 2H), 2.23 (s, 3H), 2.30e2.34 (m, 2H), 4.97 (s, 2H),
6.96e7.00 (m, 1H), 7.12e7.14 (m, 1H), 7.21 (s, 1H), 7.37 (s, 1H),
7.42e7.46 (m, 4H), 7.56e7.60 (m, 2H), 7.80e7.82 (m, 4H), 13C NMR
d
9.8, 17.6, 30.6, 52.1, 122.9, 127.6, 128.1, 128.2, 128.8, 129.0, 131.0,
133.6, 135.6, 140.0, 172.0. HRMS-ESI (m/z): calcd for C23H25N2O5S2
(100 MHz, CDCl3): d 13.8, 19.0, 19.4, 39.7, 49.8, 117.1, 121.4, 127.9,
(MþHþ): 473.1199, found 473.1192.
128.1, 128.5, 128.8, 130.0, 133.7, 137.5, 140.0, 171.1. HRMS-ESI (m/z):
calcd for C24H27N2O5S2 (MþHþ): 487.1356, found 487.1349.
4.4.11. N-(2-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)butyramide (2k)
4.4.17. N-(3-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)cyclopropanecarboxamide (2q)
Yellow solid, mp 90e92 ꢁC; IR (KBr, cmꢀ1): 1170, 1373, 1666,
2923, 3397. 1H NMR (400 MHz, CDCl3):
1.77 (q, J ¼ 7.40 Hz, 2H), 2.11 (s, 3H), 2.37 (t, J ¼ 7.20 Hz, 3H), 4.88 (s,
2H), 6.90 (s, 1H), 7.10 (s, 1H), 7.18e7.20 (m, 1H), 7.43e7.47 (m, 4H),
7.56e7.60 (m, 2H), 7.70e7.72 (m, 1H), 7.80e7.82 (m, 4H), 13C NMR
d
1.03 (t, J ¼ 7.28 Hz, 3H),
Yellow solid, mp 110e112 ꢁC; IR (KBr, cmꢀ1): 1168, 1372, 1651,
2921, 3249. 1H NMR (400 MHz, CDCl3):
d 0.84e0.96 (m, 2H),
1.08e1.11 (m, 2H), 1.46e1.50 (m, 1H), 2.27 (s, 3H), 4.97 (s, 2H),
6.95e6.97 (m, 1H), 7.12e7.15 (m, 1H), 7.38e7.46 (m, 6H), 7.56e7.60
(m, 2H), 7.80e7.82 (m, 4H), 13C NMR (100 MHz, CDCl3):
d 8.1, 17.7,
(100 MHz, CDCl3):
d 13.8, 17.6, 19.2, 39.7, 52.1, 123.0, 127.6, 128.1,
128.8, 129.0, 131.0, 133.6, 133.7, 135.6, 139.9, 171.2. HRMS-ESI (m/z):
19.4, 49.8, 116.7, 121.2, 128.0, 128.2, 128.8, 129.0, 130.0, 133.7, 137.5,
140.0, 171.9. HRMS-ESI (m/z): calcd for C24H25N2O5S2 (MþHþ):
485.1119, found 485.1124.
calcd for C24H27N2O5S2 (MþHþ): 487.1356, found 487.1358.
4.4.12. N-(2-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)cyclopropanecarboxamide (2l)
White solid, mp 155e157 ꢁC; IR (KBr, cmꢀ1): 1168, 1371, 1666,
4.4.18. N-(3-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)cyclohexanecarboxamide (2r)
2923, 3386. 1H NMR (400 MHz, CDCl3):
d 0.85e0.90 (m, 2H),
Yellow solid, mp 86e88 ꢁC; IR (KBr, cmꢀ1): 1164, 1374, 1686,
1.10e1.12 (m, 2H),1.50e1.54 (m,1H), 2.15 (s, 3H), 4.88 (s, 2H), 7.11 (s,
1H), 7.16e7.18 (m, 2H), 7.42e7.46 (m, 4H), 7.49e7.52 (m, 1H),
7.56e7.60 (m, 2H), 7.80e7.82 (m, 4H), 13C NMR (100 MHz, CDCl3):
2927, 3377. 1H NMR (400 MHz, CDCl3):
d 1.28 (s, 2H), 1.53e1.59 (m,
2H), 1.82e1.86 (m, 2H), 1.93e1.97 (m, 2H), 2.19e2.24 (m, 1H), 2.27
(s, 3H), 4.97 (s, 2H), 6.95e6.97 (m, 1H), 7.12e7.16 (m, 2H), 7.41e7.46
(m, 5H), 7.56e7.60 (m, 2H), 7.80e7.82 (m, 4H), 13C NMR (100 MHz,
d
8.1, 17.7, 18.4, 52.1, 122.7, 127.6, 128.1, 128.2, 128.8, 129.1, 129.2,
133.7, 135.9, 140.0, 171.0. HRMS-ESI (m/z): calcd for C24H25N2O5S2
(MþHþ): 485.1119, found 485.1117.
CDCl3):
d 19.4, 25.6, 25.7, 29.7, 46.5, 49.8, 117.1, 121.3, 127.8, 128.1,
128.8, 129.0, 130.0, 133.7, 137.5, 140.0, 174.4. HRMS-ESI (m/z): calcd
for C27H31N2O5S2 (MþHþ): 527.1669, found 527.1666.
4.4.13. N-(2-Methyl-4-((N-(phenylsulfonyl)phenylsulfonamido)-
methyl)phenyl)cyclohexanecarboxamide (2m)
White solid, mp 130e131 ꢁC; IR (KBr, cmꢀ1): 1168, 1372, 1657,
4.4.19. N-(4-(aminomethyl)phenyl)acetamide (3a)
2924, 3413. 1H NMR (400 MHz, CDCl3):
d
1.28e1.37 (m, 4H),
Yellow solid, mp 152e154 ꢁC; IR (KBr, cmꢀ1): 1158, 1321, 1537,
1.52e1.62 (m, 4H), 2.00e2.03 (m, 2H), 2.11 (s, 3H), 4.88 (s, 2H), 6.95
(s, 1H), 7.10 (s, 1H), 7.17e7.19 (m, 1H), 7.43e7.47 (m, 4H), 7.56e7.60
(m, 2H), 7.71 (d, J ¼ 8.14 Hz, 1H), 7.79e7.82 (m, 4H), 13C NMR
1654, 3154, 3354. 1H NMR (400 MHz, CDCl3):
d 2.16 (s, 3H),
4.10e4.11 (m, 2H), 7.13e7.18 (m, 2H), 7.40e7.42 (m, 2H), 7.51e7.54
(m, 1H), 7.58e7.62 (m, 1H), 7.87e7.89 (m, 1H), 13C NMR (100 MHz,
(100 MHz, CDCl3):
d
17.6, 25.5, 25.7, 29.8, 46.4, 52.1, 122.9, 127.6,
CDCl3): d 24.4, 46.9, 120.0, 127.1, 128.6, 129.2, 168.3. HRMS-ESI (m/
128.1, 128.8, 129.0, 130.8, 130.9, 133.6, 135.7, 140.0, 174.0. HRMS-ESI
z): calcd for C9H13N2O (MþHþ): 165.1022, found 165.1025.
Please cite this article in press as: Yang Y, et al., Metal-free remote oxidative benzylic CꢀH amination of 4-methylanilides with N-